Inventiva Revises Phase III NASH Plans For Broader Indication

 
• By Joseph Haas
Change of plans
Inventiva's revised Phase III NASH plans involve testing drug in cirrhotic patients • Source: Shutterstock

More from Clinical Trials

More from R&D